Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.84B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.48B |
| 3 |
Nike
NKE
|
+$1.17B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$922M |
| 5 |
Hewlett Packard
HPE
|
+$834M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TC Energy
TRP
|
+$1.14B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.13B |
| 3 |
Broadcom
AVGO
|
+$625M |
| 4 |
UnitedHealth
UNH
|
+$584M |
| 5 |
Mastercard
MA
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.22% |
| 2 | Financials | 9.75% |
| 3 | Consumer Discretionary | 7.43% |
| 4 | Healthcare | 7.41% |
| 5 | Industrials | 5.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5801
Castor Maritime
CTRM
$20.1M
| $60.6K | ﹤0.01% |
26,600
+4,586
| +21% | +$12K |
|
5802
Key Tronic
KTCC
$44.2M
| $60.6K | ﹤0.01% |
23,480
+9,327
| +66% | +$30.9K |
|
|
ONCY
5803
Oncolytics Biotech
ONCY
$95.1M
| $60K | ﹤0.01% |
109,098
+7,700
| +8% | +$5.63K |
|
5804
Tevogen Inc. Common Stock
TVGN
$28.9M
| $59.1K | ﹤0.01% |
1,095
-468
| -30% | -$30.8K |
|
5805
Microbot Medical
MBOT
$124M
| $57K | ﹤0.01% |
+37,744
| New | +$66.7K |
|
5806
PepGen
PEPG
$137M
| $56.5K | ﹤0.01% |
40,240
-58,104
| -59% | -$120K |
|
5807
RF Industries
RFIL
$145M
| $56.2K | ﹤0.01% |
+11,991
| New | +$54.8K |
|
5808
Aware
AWRE
$27.8M
| $54.7K | ﹤0.01% |
34,595
+14,436
| +72% | +$23.3K |
|
5809
Solarmax Technology
SMXT
$22.1M
| $54.3K | ﹤0.01% |
45,225
-28,887
| -39% | -$41.4K |
|
|
HFRO
5810
Highland Opportunities and Income Fund
HFRO
$407M
| $52.8K | ﹤0.01% |
10,157
-31,320
| -76% | -$173K |
|
5811
Seres Therapeutics
MCRB
$49.8M
| $52.2K | ﹤0.01% |
3,731
+1,083
| +41% | +$17K |
|
|
BOLD
5812
Boundless Bio
BOLD
$62.9M
| $52K | ﹤0.01% |
34,427
-14,245
| -29% | -$29.5K |
|
|
LGO
5813
Largo
LGO
$71.1M
| $51.6K | ﹤0.01% |
32,036
-3
| -0% | -$5 |
|
|
NB
5814
NioCorp Developments
NB
$731M
| $51.5K | ﹤0.01% |
26,154
-19,470
| -43% | -$39.1K |
|
5815
BioXcel Therapeutics
BTAI
$26M
| $50.3K | ﹤0.01% |
+24,794
| New | +$92.6K |
|
5816
Falcon's Beyond Global Warrants
FBYDW
$10.3M
| $50K | ﹤0.01% |
50,000
| – | – |
|
5817
Research Solutions
RSSS
$73.9M
| $49.8K | ﹤0.01% |
19,142
-18,825
| -50% | -$64.2K |
|
5818
Harte-Hanks
HHS
$16.8M
| $49K | ﹤0.01% |
+10,210
| New | +$52.1K |
|
|
REE
5819
DELISTED
REE Automotive
REE
| $48.5K | ﹤0.01% |
+18,232
| New | +$131K |
|
5820
Alliance Entertainment
AENT
$284M
| $48.2K | ﹤0.01% |
14,401
+2,020
| +16% | +$10.3K |
|
5821
CAMP4 Therapeutics
CAMP
$252M
| $47.8K | ﹤0.01% |
11,955
-5,535
| -32% | -$26.8K |
|
|
QVCGA
5822
DELISTED
QVC Group Inc Series A
QVCGA
| $47.7K | ﹤0.01% |
4,747
-999
| -17% | -$15.9K |
|
5823
Surf Air Mobility
SRFM
$91.8M
| $47K | ﹤0.01% |
17,604
-3,400
| -16% | -$14K |
|
5824
Enel Chile
ENIC
$6.21B
| $46.9K | ﹤0.01% |
14,329
-13,187
| -48% | -$42.2K |
|
|
LYRA
5825
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $46.8K | ﹤0.01% |
7,404
-3,706
| -33% | -$34.7K |
|
Similar funds
Goldman Sachs's Q1 2025 Portfolio in Review
As of Q1 2025, Goldman Sachs held 6,539 positions worth $618B, down 2.6% from $634B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Goldman Sachs's Q1 2025 filing shows 547 new, 2,373 increased, 2,724 reduced and 514 closed positions. Its largest new stake was Fidelity Enhanced Large Cap Core ETF: 2,339,740 shares worth $73M. The largest sale was TC Energy, an estimated $1.14B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Goldman Sachs's largest Q1 2025 buy was Fidelity Enhanced Large Cap Core ETF: 2,339,740 shares worth $73M.
- Goldman Sachs added most to iShares Russell 2000 ETF in Q1 2025, an estimated $1.84B increase.
- Goldman Sachs's biggest Q1 2025 reduction was TC Energy, cutting an estimated $1.14B.
- Goldman Sachs fully exited ENLINK MIDSTREAM, LLC in Q1 2025, selling an estimated $242M.
- Goldman Sachs's ten largest holdings make up 20% of its $618B portfolio in Q1 2025.
- Goldman Sachs opened 547 new positions and closed 514 in Q1 2025.
- Goldman Sachs's portfolio value fell 2.6% quarter-over-quarter to $618B.
Based on Goldman Sachs's 13F filing for Q1 2025, filed 9 May 2025.